Apollon Formularies inks agreements with 'over a dozen' cannabis growers in Jamaica

Apollon Formularies PLC (AQSE:APOL) has signed what it describes as tripartite agreements with Cannabis License Authority-approved growers in Jamaica.

It said it has agreed ‘more than a dozen’ of these tie-ups to provide consistent availability of large quantities of high-quality, fresh harvests of buds.

This will also allow Apollon to accelerate the processing and manufacturing of medical cannabis products for patients, clinical trials, and export.

The CLA sign-off ensures the product meets certain standards and that best practices are adopted.

"We are pleased that so many CLA-licensed cultivators have signed tripartite agreements with the company indicating their interest and willingness to grow and provide substantial quantities of high-quality, freshly harvested cannabis buds to be used by Apollon to process and manufacture large quantities of medical cannabis products which will significantly accelerate and increase our inventory for patients, clinical trials, and export," said chief executive Stephen Barnhill.

Apollon is a medical cannabis group developing treatments for cancer and the pain associated with the disease from its base in Jamaica.

< Back to News